在进展期恶性肿瘤背景下的非肿瘤性肠梗阻

doi:0.16689/j.cnki.cn11-9349/r.2019.03.018

摘要
图/表
参考文献
相关文章 (15)

全文: PDF (1188 KB) HTML (1 KB)
输出: BibTeX | EndNote (RIS)

摘要目的恶性肠梗阻为进展期恶性肿瘤患者常见的并发症，以往认为恶性肠梗阻是一个标志性的终末事件。多项研究表明，对于恶性肠梗阻患者的治疗应以个体化姑息治疗为核心，进行终末期关怀治疗。方法 2例恶性肿瘤背景下的非肿瘤性肠梗阻的患者均既往罹患腹部恶性肿瘤，均为胃恶性肿瘤。患者在肿瘤规范治疗后1年左右出现肠梗阻，其临床表现明确，1例患者持续3个月表现为不全肠梗阻-完全肠梗阻反复转换，1例患者表现为骤然发作的完全性肠梗阻。均经过以手术为核心的治疗使2例患者受益，改善生活质量，获得进一步治疗机会，并延长生存期。结果恶性肠梗阻的治疗需要多学科协作共同完成，其整体预后不佳，2位患者均通过手术获益较少见，准确的术前评估和完善的围术期治疗为患者赢得更多机会。结论医生不应因为恶性肠梗阻的整体预后不佳，就放弃对患者个体的解除梗阻的尝试，通过合理的评估、规范的治疗、积极的手术探查，可以对患者获得良好生存质量和继续姑息治疗机会产生积极的影响。

	服务

	把本文推荐给朋友
	加入我的书架
	加入引用管理器
	E-mail Alert
	RSS
	作者相关文章
	张骁玮
	石汉平

关键词 ：肠梗阻, 进展期肿瘤, 手术

Abstract：Objective Malignant intestinal obstruction is a common complication of patients with advanced malignant tumors. Malignant intestinal obstruction was previously considered to be a terminal event. Previous studies have shown that the treatment of patients with malignant intestinal obstruction should be treated with end-stage care， focusing on individualized palliative care. Methods Two patients with non-maligment bowel obstruction in the context of advanced cancer were previously suffering from abdominal malignant tumors， both of which were gastric malignant tumors. The patient developed intestinal obstruction about 1 year after the standard treatment of the tumor， and the clinical manifestations were clear. One patient had recurrent symptoms between incomplete intestinal obstruction and complete intestinal obstruction for 3 months. One patient showed a complete intestinal obstruction with sudden onset. Both patients benefited from surgery-centered treatment， leading to improved quality of life， obtaining further treatment opportunities， and prolonged survival. Results The treatment of malignant bowel obstruction requires multidisciplinary collaboration. Its overall prognosis is poor. The two patients got benefit through surgery. From these two cases we learned that accurate preoperative assessment and improved perioperative treatment will give patients more opportunities. Conclusion Doctors should not give up attempts to relieve obstruction of individual patients because of the poor overall prognosis of malignant intestinal obstruction. Through reasonable evaluation， standardized treatment， and active surgical exploration， patients can obtain good quality of life and continue palliative treatment opportunities.

Key words： Intestinal obstruction Advanced cancer Surgery

基金资助:国家重点研发计划项目（2017YFC1309200）

通讯作者: 石汉平，电子邮箱：shihp@ccmu.edu.cn

引用本文:

张骁玮，石汉平. 在进展期恶性肿瘤背景下的非肿瘤性肠梗阻[J]. 肿瘤代谢与营养电子杂志, 2019, 6(3): 361-364.
ZHANG Xiao-wei， SHI Han-ping. Non-maligment bowel obstruction in the context of advanced cancer. Electron J Metab Nutr Cancer, 2019, 6(3): 361-364.

1.赵玉沛，陈孝平等.外科学.第3版.北京:人民卫生出版社.2016;489-494.
2.姜泊等.胃肠病学.第1版.北京:人民卫生出版社.2015;148-155.
3.孙家邦，李铎. 机械性、麻痹性、假性肠梗阻的鉴别诊断与治疗. 中国胃肠外科杂志.1999;(2):67-70.
4.Yen CH， Chen JD， Tui CM， et al. Internal hernia: computed tomography diagnosis and differentiation from adhesive small bowel obstruction. J Chin Med Assoc. 2005;68:21-28.
5.于世英，王杰军，王金万，等. 晚期癌症患者合并肠梗阻治疗的专家共识. 中华肿瘤杂志. 2007;29(8):637-640.
6.赵禹锡，王锡山.恶性肠梗阻的诊断与治疗.中华结直肠疾病电子杂志.2015;4(5):538-539.
7.Levy MH， Smith TJ， Alvarezperez A， et al. Palliative care， version 1.2014 featured updates to the NCCN guidelines. J Natl Compr Canc Netw. 2014;12(10):1379-1388.
8.Hisanagatakayuki， Shinjotakuya， Imaikengo， et al. Clinical guidelines for management of gastrointestinal symptoms in cancer patients: the Japanese society of palliative medicine recommendations. J Palliat Med. 2019;22(8):986-997.
9.Maung AA， Johnson DC， Piper GL， et al. Evaluation and management of small-bowel obstruction: an eastern association for the surgery of trauma practice management guideline. J Trauma Acute Care Surq.2012;73(5 suppl 4):S362-S369.
10.Anthony T， Baron T， Mercadante S， et al. Report of the clinical protocol committee: development of randomized trials for malignant bowel obstruction. J Pain Symptom Manage. 2007;34(1 Suppl):S49-S59.
11.Mirensky TL， Schuster KM， Ali UA， et al. Outcomes of small bowel obstruction in patients with previous gynecologic malignancies. Am J Surg. 2012;203(4):472-479.
12.Chakraborty A， Selby D， Gardiner K， et al. Malignant bowel obstruction: natural history of a heterogeneous patient population followed prospectively over two years. J Pain Symptom Manage. 2011;41(2):412-420.
13.Olson TJ， Pinkerton C， Brasel KJ， et al. Palliative surgery for malignant bowel obstruction from carcinomatosis: a systematic review. JAMA Surgery.2014;149(4):383-392.
14.Dolan EA. Malignant bowel obstruction: a review of current treatment strategies. Am J Hosp Palliate Care. 2011;28(8):576-582.
15.Ripamonti C， Bruera E. Palliative management of malignant bowel obstruction. Int J Gynecol Cancer. 2002;12(2):135-143.
16.Ripamonti CI， Easson AM， Gerdes H. Management of malignant bowel obstruction. Eur J Cancer. 2008;44(8):1105-1115.
17.Wong TH， Tan YM. Surgery for the palliation of intestinal obstruction in advanced abdominal malignancy. Singapore Med J. 2009;50(12):1139-1144.
18.Pujara D， Chiang YJ， Cormier JN， et al. Selective approach for patients with advanced malignancy and gastrointestinal obstruction. J Am Coll Surg.2017;225(1):53-59.
19.Henry JC， Pouly S， Sullivan R， et al. A scoring system for the prognosis and treatment of malignant bowel obstruction. Surgery. 2012;152(4):747-756.
20.Chi D S， Phaeton R， Miner T J， et al. A prospective outcomes analysis of palliative procedures performed for malignant intestinal obstruction due to recurrent ovarian cancer. Oncologist. 2009;14(8):835-839.
21.B V O， Me VD， Planting AS， et al. Surgical treatment or gastric drainage only for intestinal obstruction in patients with carcinoma of the ovary or peritoneal carcinomatosis of other origin. Surg Gynecol Obstet.1993;176(5):469-474.
22.Maeda Y， Shinohara T， Katayama T， et al. A laparoscopic approach is associated with a decreased incidence of SSI in patients undergoing palliative surgery for malignant bowel obstruction. Int J Surg.2017;42:90-94.